Posts Tagged ‘Funding’
StudentsPool wins the 10th Patient Quality of Life Challenge
Led by Isa Dupont, a nurse, and Gaspard Chevassus, an engineer, the StudentsPool project is reinventing ad hoc recruitment and connecting students with healthcare institutions to offer assignments serving patients. The project, selected among 5 finalists, received a CHF 25,000 support. The constant turnover of temporary staff undermines the quality of care. Faced with this…
Read MoreTestmate Health Partners with Intermountain Health
Testmate Health and Intermountain Health have announced a strategic partnership and investment to accelerate access to rapid, low-cost molecular tests for sexually transmitted infections (STIs) in the U.S. This collaboration positions Intermountain Health and Testmate Health to bring lab-quality STI diagnostics to at-risk communities. STIs remain a largely silent epidemic, with 80% of chlamydia and…
Read MoreVivent Biosignals, global leader in digital crop diagnostics, raises CHF 7 Million
Vivent Biosignals, the Vaud-based pioneer of “wearables for plants”, has announced new investment from Agri Investment Fund (AIF), Horticoop, Pymwymic and Swiss private investors. The funding will accelerate Vivent’s commercial scaling of its breakthrough plant biosignal monitoring technology, which is transforming crop management and sustainable food production. “We are thrilled to welcome Agri Investment Fund…
Read MoreThe Swiss Health Valley Shines with Multiple Innovation Awards
The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In recent weeks, several startups and innovators from our ecosystem have been honoured with prestigious awards, highlighting the region’s exceptional dynamism and creativity. MoleSense wins the Swiss Innovation Challenge Before an audience of nearly 4,000 people,…
Read MoreBioArk & New Mexico Venture Studios Partner to Boost Life Sciences Projects
BioArk & New Mexico Venture Studios have established a strategic partnership to support startups in life sciences, medtech, and deep tech. This alliance facilitates access to infrastructure, expertise, and markets between US and European markets, accelerating international growth and collaboration. Facilitating startup expansion and collaboration The partnership provides startup exchange programs, shared lab and…
Read MoreBioLNP Innovation and OneCell Protein, recipients of the EPFL Startup Launchpad Ignition Grant
Two EPFL-based startups: BioLNP Innovation and OneCell Protein, have become the latest recipients of the EPFL Startup Launchpad Ignition grant. The startups were each awarded a CHF30,000 grant to continue developing their technology. BioLNP Innovation Viruses (including Respiratory Syncytial Virus or Hepatitis B) are a major public health concern. While scientists have developed treatments…
Read MoreFIF Funding Supports Four Life Sciences Startups: Reverso Therapeutics, Harantech, Vibrant and Joipaw
Four innovative startups from Geneva developing solutions in pet health, life sciences, and digital therapeutics have received support from the FONGIT Innovation Fund (FIF). Harantech and Reverso Therapeutics, both UNIGE spin-offs, along with Vibrant, a Wyss Center project, each received a CHF 50,000 FIF Grant to support the translation of their research into tangible health…
Read MoreAzureCell Therapies and Myriad Optics Awarded by Gebert Rüf Stiftung Innobooster Programme
Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf Stiftung programme: AzureCell Therapies and Myriad Optics. AzureCell Therapies | Bilal Fares, University of Geneva Every 9 min, a new patient is diagnosed with Parkinson’s, a condition long considered incurable due to the irreversible loss…
Read MoreBreaking Through Cancer’s Soft Defense: A Revolutionary Swiss Approach
Swiss researchers from EPFL, University of Geneva, and HUG hospitals are pioneering a groundbreaking strategy to overcome immunotherapy resistance by targeting cancer cells’ physical properties rather than their biology. The project received a CHF 1,4 million grant from Foundation Leenaards. “Our approach targets the mechanical properties of cancer cells by making their membranes stiffer, which…
Read MoreBeech Biotech Awarded $1.9 million by the Gates Foundation
Beech Biotech, a Lausanne-based biopharmaceutical company creating “Mother only” monoclonals to treat complications of pregnancy, has been awarded a $1.9 million grant by the Gates Foundation for the development of its breakthrough therapeutic approach in preeclampsia. Preeclampsia is a leading cause worldwide of maternal morbidity and mortality, premature birth, stillbirth, and neonatal death. Each…
Read More